Literature DB >> 17009397

Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue.

Matteo Massi1, Pierfranco Ioan, Roberta Budriesi, Alberto Chiarini, Beatrice Vitali, Karen M Lammers, Paolo Gionchetti, Massimo Campieri, Anthony Lembo, Patrizia Brigidi.   

Abstract

AIM: To evaluate the intestinal motility changes evoked by 8 bacterial strains belonging to Bifidobacterium, Lactobacillus and Streptococcus genera within the probiotic preparation VSL#3.
METHODS: Ileum and proximal colon segments isolated from guinea-pigs were used as a study model. Entire cells and cell fractions (cell debris, cell wall fraction, cytoplasmatic fraction, proteinaceous and non-proteinaceous cytoplasmatic components) of VSL#3 strains and, as controls, Escherichia coli, Salmonella aboni and Bacillus licheniformis were tested in this in vitro model.
RESULTS: Among the bacterial cell fractions tested, only the cytoplasmatic fraction modified intestinal motility. Lactobacillus strains stimulated the contraction of ileum segment, whereas all probiotic strains tested induced proximal colon relaxation response. The non-proteinaceous cytoplasmatic components were responsible for the colon relaxation.
CONCLUSION: The results obtained in this study suggest that the proximal colon relaxation activity showed by the probiotic bacteria could be one of the possible mechanisms of action by which probiotics exert their positive effects in regulating intestinal motility.

Entities:  

Mesh:

Year:  2006        PMID: 17009397      PMCID: PMC4124406          DOI: 10.3748/wjg.v12.i37.5987

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers.

Authors: 
Journal:  J Travel Med       Date:  1997-03-01       Impact factor: 8.490

Review 3.  Protection from gastrointestinal diseases with the use of probiotics.

Authors:  P R Marteau; M de Vrese; C J Cellier; J Schrezenmeir
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.

Authors:  P Brigidi; B Vitali; E Swennen; G Bazzocchi; D Matteuzzi
Journal:  Res Microbiol       Date:  2001-10       Impact factor: 3.992

Review 6.  Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.

Authors:  H Szajewska; J Z Mrukowicz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-10       Impact factor: 2.839

7.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

8.  Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings.

Authors:  Jean-Pierre Chouraqui; Louis-Dominique Van Egroo; Marie-Claire Fichot
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-03       Impact factor: 2.839

9.  Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.

Authors:  Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Paolo Gionchetti; Fernando Rizzello; Elisabetta Caramelli; Diego Matteuzzi; Massimo Campieri
Journal:  FEMS Immunol Med Microbiol       Date:  2003-09-22

10.  A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.

Authors:  H J Kim; M Camilleri; S McKinzie; M B Lempke; D D Burton; G M Thomforde; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2003-04-01       Impact factor: 8.171

View more
  13 in total

1.  Quantitative studies of the regular distribution pattern for Salmonella enteritidis in the internal organs of mice after oral challenge by a specific real-time polymerase chain reaction.

Authors:  Shu-Xuan Deng; An-Chun Cheng; Ming-Shu Wang; Ping Cao; Bin Yan; Nian-Chun Yin; Sheng-Yan Cao; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

2.  The population of a high-virulence strain of Salmonella enterica serovar Enteritidis in subcutaneously infected partridge: a quantitative time-course study using real-time PCR.

Authors:  Guang-Zhi He; Wei-Yi Tian; Ning Qian; Shu-Xuan Deng; Chuan-Wei An; Yong Feng
Journal:  Vet Res Commun       Date:  2011-05-19       Impact factor: 2.459

3.  Lactobacillus species shift in distal esophagus of high-fat-diet-fed rats.

Authors:  Xin Zhao; Xiao-Wei Liu; Ning Xie; Xue-Hong Wang; Yi Cui; Jun-Wen Yang; Lin-Lin Chen; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

4.  Recovery from dietary iron deficiency anaemia in rats by the intake of microencapsulated ferric saccharate.

Authors:  Elisabet Lázaro; Jonathan Santas; Magda Rafecas
Journal:  J Food Sci Technol       Date:  2017-06-19       Impact factor: 2.701

5.  Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial.

Authors:  Paula V P Guerra; Luiza N Lima; Tassia C Souza; Vanessa Mazochi; Francisco J Penna; Andreia M Silva; Jacques R Nicoli; Elizabet V Guimarães
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

6.  The Effects of Lactobacillus acidophilus on the Intestinal Smooth Muscle Contraction through PKC/MLCK/MLC Signaling Pathway in TBI Mouse Model.

Authors:  Bo Sun; Chen Hu; Huan Fang; Lina Zhu; Ning Gao; Jingci Zhu
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 7.  Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.

Authors:  Michele Pier Luca Guarino; Michele Cicala; Lorenza Putignani; Carola Severi
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

8.  Effects of Saccharomyces cerevisiae or boulardii yeasts on acute stress induced intestinal dysmotility.

Authors:  Christine West; Andrew M Stanisz; Annette Wong; Wolfgang A Kunze
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

9.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09

10.  Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro.

Authors:  Jing Gong; Tao Bai; Lei Zhang; Wei Qian; Jun Song; Xiaohua Hou
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.